Marco Strub
Vermögen: 255 049 $ am 30.09.2026
Vermögen: 255 049 $ am 30.09.2026
Mr. Marco A. Strub is an Independent Director at Riverside Resources, Inc., an Independent Director at TAAL Distributed Information Technologies, Inc., an Independent Director at Triumph Gold Corp., an Independent Director at ZincX Resources Corp.
and a Chief Executive Officer & Principal at Sircon AG.
He is on the Board of Directors at Riverside Resources, Inc., TAAL Distributed Information Technologies, Inc., Triumph Gold Corp., E3 Lithium Ltd., ZincX Resources Corp., Clarrence AG and KOP Therapeutics Corp.
Mr. Strub was previously employed as an Independent Director by E3 Lithium Ltd., an Independent Director by Margaret Lake Diamonds, Inc., an Independent Director by Open Gold Corp., and a Partner by Exulta AG.
He also served on the board at Margaret Lake Diamonds, Inc. and MVE Capital Corp.
He received his graduate degree from the University of St. Gallen and an MBA from the University of St. Gallen.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.09.2026 | 580’000 ( 0.31% ) | 117 160 $ | 30.09.2026 | |
| 20.04.2026 | 250’000 ( 0.33% ) | 73 750 $ | 30.09.2026 | |
TRIUMPH GOLD CORP. 0.19% | 12.05.2025 | 135’600 ( 0.19% ) | 64 139 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ZINCX RESOURCES CORP. | Direktor/Vorstandsmitglied | 01.11.2004 |
| TRIUMPH GOLD CORP. | Direktor/Vorstandsmitglied | 09.05.2011 |
| TAAL DISTRIBUTED INFORMATION TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 25.10.2018 |
| RIVERSIDE RESOURCES INC. | Direktor/Vorstandsmitglied | 17.06.2026 |
| E3 LITHIUM LIMITED | Direktor/Vorstandsmitglied | 01.01.2011 |
Sircon AG | Vorstandsvorsitzender | 01.03.2003 |
Clarrence AG
Clarrence AG Investment ManagersFinance Provides investment services | Direktor/Vorstandsmitglied | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology Develops genomic drug platform for cancer | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| VAULT STRATEGIC MINING CORP. | Direktor/Vorstandsmitglied | 23.04.2014 |
| ░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
E3 Lithium Ltd.
E3 Lithium Ltd. Chemicals: SpecialtyProcess Industries Explores and develops lithium projects | Process Industries |
ZincX Resources Corp.
ZincX Resources Corp. Other Metals/MineralsNon-Energy Minerals Engages in the exploration and development of mineral properties | Non-Energy Minerals |
Triumph Gold Corp.
Triumph Gold Corp. Precious MetalsNon-Energy Minerals Explores mineral resources | Non-Energy Minerals |
MVE Capital Corp.
MVE Capital Corp. Financial ConglomeratesFinance Capital pool company | Finance |
Riverside Resources, Inc.
Riverside Resources, Inc. Precious MetalsNon-Energy Minerals Engages in the acquisition, exploration and development of mineral properties | Non-Energy Minerals |
Vault Strategic Mining Corp.
Vault Strategic Mining Corp. Other Metals/MineralsNon-Energy Minerals Engages in mining diamonds | Non-Energy Minerals |
TAAL Distributed Information Technologies, Inc.
TAAL Distributed Information Technologies, Inc. Data Processing ServicesTechnology Services Operates as a blockchain service provider | Technology Services |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exulta AG | |
Sircon AG | |
Open Gold Corp.
Open Gold Corp. Precious MetalsNon-Energy Minerals Engages in the exploration and development gold, copper and silver mines | Non-Energy Minerals |
Clarrence AG
Clarrence AG Investment ManagersFinance Provides investment services | Finance |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology Develops genomic drug platform for cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen